Companies Dominating the Synthetic Biology Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Agilent Technologies Inc.
- Danaher Corporation
- GenScript Biotech Corporation
- Twist Bioscience Corporation
- Amyris, Inc.
- Intrexon Corporation
- Synthetic Genomics Inc.
- Codexis, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Synthetic Biology Market in 2025 is assessed at USD 22.15 billion.
The global market size was worth over USD 19.04 billion in 2024 and is poised to grow at a CAGR of around 20.4%, reaching USD 212.72 billion revenue by 2037.
North America is anticipated to bring in USD 74.45 billion by 2037, driven by growing population, research activity, and health insurance coverage for synthetic biology treatments.
The major players in the market include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Danaher Corporation, GenScript Biotech Corporation, Twist Bioscience Corporation, Amyris, Inc., Intrexon Corporation, Synthetic Genomics Inc., Codexis, Inc.
